Skip to content
Recall Observatory FDA recall evidence

Drug product

Quetiapine Fumarate Extended-Release Tablets, 200 mg, 100 tablets per unit dose carton, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454775 India; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA. NDC: 0904-6803-61

D-1001-2020

February 27, 2020

Class III

Product summary

Firm
The Harvard Drug Group
Event
Event 85138
Status
Terminated
Classification
Class III
Quantity
115 cartons
Official record key
drug-enforcement:D-1001-2020

Official wording

Reason: Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.

Code information: Lot, expiry: Lot N00037, exp 05/2021

Distribution pattern: Nationwide

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling; Incorrect or Missing